期刊文献+

NT-proBNP 侧向免疫层析荧光定量检测方法的建立及性能评价 被引量:5

Development and performance evaluation of a novel quantitative fluorescence immunochromatography for NT-proBNP
原文传递
导出
摘要 目的:建立适用于POCT的人血清N末端B型钠尿肽原(NT-proBNP)荧光定量检测方法。方法采用免疫荧光双抗体夹心法,研制快速定量检测人血清中NT-proBNP的免疫层析检测试剂盒;通过检测线性、精密度、准确度、特异性、稳定性等指标进行试剂盒的实验室性能评估;并选取2013年2月至2014年4月广东省第二人民医院、中山大学孙逸仙纪念医院和郑州市儿童医院疑似心血管疾病患者1056例(男性605例,女性451例),采集其血清标本,通过研制试剂与参比试剂的多中心、平行比对研究进行试剂盒临床应用评估。采用相关分析、线性回归、受试者工作特征( ROC)曲线分析、阴/阳性符合率统计学方法对数据进行统计分析。结果 NT-proBNP定量试剂报告范围为18~35000 ng/L;试剂在重复检测低、中、高3个浓度校准品的变异系数( CV)小于15%,偏倚小于20%;标本中常见干扰物胆红素、甘油三酯、胆固醇在所测定的浓度下,测试结果的CV值可控制在15%以内,对NT-proBNP定量检测无明显影响;14个月内检测不同浓度的NT-proBNP校准品,偏倚可以控制在±20%以内,试剂有效期大于12个月;在临床样本的检测中,本试剂盒与参比试剂产品有较好的相关性(Y研制=1.0489X参比+121.54,R2=0.9566,n=1056),并且对临床血清标本定量结果的偏差无统计学意义( Z=0.88,P=0.379>0.05);研制的NT-proBNP检测结果以参考试剂结果为标准进行比对,在2个不同cut-off 值(300和450 ng/L )下的 ROC 曲线下面积分别为0.981和0.978。结论本研究建立的NT-proBNP免疫荧光定量层析检测方法及相应的试剂,在各项指标的评估中均达到临床检测的要求,可用于血清NT-proBNP 指标的快速检测。 Objective To develop a rapid quantitative detecting assay for point-of-care testing ( POCT ) of N-terminal pro-brain natriuretic peptide ( NT-proBNP ) in serum by the fluorescence immunochromatographic technology.Methods Applying double-antibody sandwich assay to establish the quantitative NT-proBNP kit.The performance of quantitative NT-proBNP kit was evaluated by the sensitivity , specificity, accuracy, precision, stability and clinical effectiveness.It compared the research kit and conference kit by the parallel experience in the 1 056(605 males, 451 females)serum specimen collected from Guangdong Provincial People′s Hospital, Sun Yat-sen Memorial Hospital and Children′s Hospital of Zhengzhou between February 2013 to April 2014.Statistical significance of the results was assessed by correlation analysis , linear regression , receive operating characteristic ( ROC) curve analysis , negative and positive consistent.Results The report range of the NT-proBNP kit was 18-35 000 ng/L.The coefficient of variation ( CV) values for low , median and high concentration calibrators respectively were all less than 15%.Common interfering substances in human serum specimens such as bilirubin , triglyceride and cholesterol were found no significant affect on NT-proBNP antigen detection and the CV were no more than 15%.According to the results of detection for calibrators , the shelf time of the NT-proBNP diagnostic kit should be longer than 12 months.The NT-proBNP kit and reference kit had good correlation ( Y=1.048 9X developed reference +121.54, R2 =0.956 6, n=1 056) to detect the target protein through the parallel experiments and the deviation of the quantitative results of clinical serum samples showed no statistical significance (Z=0.88, P=0.379>0.05).The clinical assays of two different diagnostic kits showed good consistency based on the ROC curve evaluation which is compared by two cut-off values (300 and 450 ng/L).The areas under ROC curve were 0.981 and 0.978 respectively.Conclusions A novel NT-proBNP chromatographic quantitative immunofluorescence detection method was developed in this study .The performance evaluation data indicated that the kit is suitable for rapid detection of serum NT -proBNP.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第11期842-846,共5页 Chinese Journal of Laboratory Medicine
基金 国家科技部创新基金(12C26214405405) 广东省战略性新兴产业省级核心攻关(2012A080800007)
关键词 肽碎片 利钠肽 免疫层析法 心力衰竭 荧光 Peptide fragments Natriuretic peptide,brain Immunochromatography Heart failure Fluorescence
  • 相关文献

参考文献11

  • 1Maries L, Manitiu I. Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP) [J]. Cardiovasc J Afr, 2013, 24:286-289.
  • 2McKie PM, AbouEzzeddine OF, Scott CG, et al. High-sensitivity troponin I and amino-terminal pro-B-type natriuretic peptide predict heart failure and mortality in the general population [ J ]. Clin Chem, 2014, 60:1225-1233.
  • 3Palazzuoli A, Beltrami M, Ruocco G, et al. The role of natriuretic peptides for the diagnosis of left ventricular dysfunction [ J]. ScientificWorldJournal, 2013, 2013:784670.
  • 4FDA (2010), Premarket Notification, 510 (k) for Elecsys proBNP II STAT Assay [ EB/OL ]. [ 2010-03-05 ]. http://www. accessdata, fda. gov/cdrh_docs/pdfg/k092649, pdf.
  • 5丛玉隆.POCT的临床应用与存在的问题[J].中华检验医学杂志,2007,30(12):1325-1328. 被引量:83
  • 6唐时幸,康可人,李银太.疾病体外检测和诊断技术的新发展[J].中国医药生物技术,2011,6(6):401-404. 被引量:2
  • 7IFCC(2012). Maksimiljan Gorenjak, MSc. Natriuretic peptides in assessment of ventricular dysfunction [ EB/OL].http:// www. ifcc. org/ifccfiles/docs/1402062003011, pdf.
  • 8IFCC (2007) . Roberto Latini, Serge Masson. NT-proBNP: A guide to improve the management of patients with heart failure [EB/OL]. http://www, ifcc. org/media/251278/03_Latini. pdf.
  • 9Iwasaki M, Joki N, Tanaka Y, et al. Efficacy of N-terminal pro- brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients[J]. Nephrology (Carlton), 2013, 18:497-504.
  • 10Velibey Y, Golcuk Y, Goleuk B, et al. Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure[J]. 2013, 31:1634-1637.

二级参考文献22

  • 12011中国诊断试剂市场趋势观察研究预测报告.[2011-11-24].http://www.chinayearbook.com/report/book_83809.htm.
  • 2Allhoff E Lin P, Moore D. What is nanotechnology and why does it matter: from science to ethics. Hoboken, NJ: John Wiley and Sons,2010:3-5.
  • 3Agrawal A, Tripp RA, Anderson L J, et al. Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. J Virol, 2005, 79(13):8625-8628.
  • 4Wilson R. The use of gold nanoparticles in diagnostics and detection. Chem Soc Rev, 2008, 37(9):2028-2045,.
  • 5Tang S, Hewlett IK. Europium nanoparticle-based immunoassays for sensitive detection of pathogens. Chem Today, 2009, 27(6):50-52.
  • 6Tang S, Zhao J, Storhoff JJ, et al. Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J Acquit Immune Defic Syndr, 2007, 46(2):231-237.
  • 7Nam JM, Thaxton CS, Mirkin CA. Nanoparficle-based bio-bar codes for the ultrasensitive detection of proteins. Science, 2003, 301(5641): 1884-1886.
  • 8Mason JT, Xu L, Sheng ZM, et al. A liposome-PCR assay for the ultrasensitive detection of biological toxins. Nat Biotechnol, 2006, 24(5):555-557.
  • 9Wang J, Liu G, Jan MR. Ultrasensitive electrical biosensing of proteins and DNA: carbon-nanotube derived amplification of the recognition and transduction events. J Am Chem Soc, 2004, 126(10): 3010-3011.
  • 10Iino R, Araki S, Kim SH, et al. Femtoliter microdropleti array device for single-molecule digital enzyme-linked immunosorbent assay// 15TH Conference on Miniaturized Systems for Chemistry and Life Sciences. Seattle, USA: 2011.

共引文献83

同被引文献118

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部